Pharma Mar | PHM - Cash And Equivalent


Pharma Mar reported EUR17.82M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Akebia Therapeutics USD 184.84M 18.4M Dec/2025
Alaunos Therapeutics USD 1.94M 941K Sep/2025
Almirall EUR 337.77M 14.83M Dec/2025
Avita Medical AUD 10.24M 1.98M Dec/2025
Dianthus Therapeutics USD 51.09M 4.9M Dec/2025
Ionis Pharmaceuticals USD 2.68B 437M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Laboratorios Farma EUR 46.11M 18.92M Jun/2025
Moderna USD 2.6B 1.46B Dec/2025
Organon & Co USD 672M 73M Sep/2025
Pharma Mar EUR 17.82M 3.78M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Tectonic Therapeutic USD 253.8M 14.64M Dec/2025
Viatris USD 1.32B 347.1M Dec/2025
Xeris Pharmaceuticals USD 111.04M 19.44M Dec/2025